Global Microbiome Drugs Market Insights and Forecast to 2028

Publisher Name :
Date: 13-Jan-2022
No. of pages: 119
Inquire Before Buying

Microbiome Drugs market is segmented by players, region (country), by Type and by Symptom. Players, stakeholders, and other participants in the global Microbiome Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Symptom for the period 2017-2028.

Segment by Type

- Oral Dosage Form

- Enteric Capsules

Segment by Symptom

- Gastrointestinal Disorders

- Autoimmune Disorders

- Diabetes

- Cancer

- Others

By Company

- Seres Therapeutics

- Assembly Biosciences

- Synthetic Biologics

- Interxon

- PureTech

- Synlogic

- Enterome BioScience

- 4D Pharma

- Second Genome

- AOBiome

- Rebiotix

- Metabiomics

- Ritter Pharmaceuticals

- Symberix

- OpenBiome

- Azitra

- Osel

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Global Microbiome Drugs Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microbiome Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral Dosage Form
1.2.3 Enteric Capsules
1.3 Market by Symptom
1.3.1 Global Microbiome Drugs Market Size Growth Rate by Symptom, 2017 VS 2021 VS 2028
1.3.2 Gastrointestinal Disorders
1.3.3 Autoimmune Disorders
1.3.4 Diabetes
1.3.5 Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Microbiome Drugs Market Perspective (2017-2028)
2.2 Microbiome Drugs Growth Trends by Region
2.2.1 Microbiome Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Microbiome Drugs Historic Market Size by Region (2017-2022)
2.2.3 Microbiome Drugs Forecasted Market Size by Region (2023-2028)
2.3 Microbiome Drugs Market Dynamics
2.3.1 Microbiome Drugs Industry Trends
2.3.2 Microbiome Drugs Market Drivers
2.3.3 Microbiome Drugs Market Challenges
2.3.4 Microbiome Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microbiome Drugs Players by Revenue
3.1.1 Global Top Microbiome Drugs Players by Revenue (2017-2022)
3.1.2 Global Microbiome Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Microbiome Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Microbiome Drugs Revenue
3.4 Global Microbiome Drugs Market Concentration Ratio
3.4.1 Global Microbiome Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microbiome Drugs Revenue in 2021
3.5 Microbiome Drugs Key Players Head office and Area Served
3.6 Key Players Microbiome Drugs Product Solution and Service
3.7 Date of Enter into Microbiome Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Microbiome Drugs Breakdown Data by Type
4.1 Global Microbiome Drugs Historic Market Size by Type (2017-2022)
4.2 Global Microbiome Drugs Forecasted Market Size by Type (2023-2028)
5 Microbiome Drugs Breakdown Data by Symptom
5.1 Global Microbiome Drugs Historic Market Size by Symptom (2017-2022)
5.2 Global Microbiome Drugs Forecasted Market Size by Symptom (2023-2028)
6 North America
6.1 North America Microbiome Drugs Market Size (2017-2028)
6.2 North America Microbiome Drugs Market Size by Type
6.2.1 North America Microbiome Drugs Market Size by Type (2017-2022)
6.2.2 North America Microbiome Drugs Market Size by Type (2023-2028)
6.2.3 North America Microbiome Drugs Market Share by Type (2017-2028)
6.3 North America Microbiome Drugs Market Size by Symptom
6.3.1 North America Microbiome Drugs Market Size by Symptom (2017-2022)
6.3.2 North America Microbiome Drugs Market Size by Symptom (2023-2028)
6.3.3 North America Microbiome Drugs Market Share by Symptom (2017-2028)
6.4 North America Microbiome Drugs Market Size by Country
6.4.1 North America Microbiome Drugs Market Size by Country (2017-2022)
6.4.2 North America Microbiome Drugs Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Microbiome Drugs Market Size (2017-2028)
7.2 Europe Microbiome Drugs Market Size by Type
7.2.1 Europe Microbiome Drugs Market Size by Type (2017-2022)
7.2.2 Europe Microbiome Drugs Market Size by Type (2023-2028)
7.2.3 Europe Microbiome Drugs Market Share by Type (2017-2028)
7.3 Europe Microbiome Drugs Market Size by Symptom
7.3.1 Europe Microbiome Drugs Market Size by Symptom (2017-2022)
7.3.2 Europe Microbiome Drugs Market Size by Symptom (2023-2028)
7.3.3 Europe Microbiome Drugs Market Share by Symptom (2017-2028)
7.4 Europe Microbiome Drugs Market Size by Country
7.4.1 Europe Microbiome Drugs Market Size by Country (2017-2022)
7.4.2 Europe Microbiome Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Microbiome Drugs Market Size (2017-2028)
8.2 Asia-Pacific Microbiome Drugs Market Size by Type
8.2.1 Asia-Pacific Microbiome Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Microbiome Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Microbiome Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific Microbiome Drugs Market Size by Symptom
8.3.1 Asia-Pacific Microbiome Drugs Market Size by Symptom (2017-2022)
8.3.2 Asia-Pacific Microbiome Drugs Market Size by Symptom (2023-2028)
8.3.3 Asia-Pacific Microbiome Drugs Market Share by Symptom (2017-2028)
8.4 Asia-Pacific Microbiome Drugs Market Size by Region
8.4.1 Asia-Pacific Microbiome Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Microbiome Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Microbiome Drugs Market Size (2017-2028)
9.2 Latin America Microbiome Drugs Market Size by Type
9.2.1 Latin America Microbiome Drugs Market Size by Type (2017-2022)
9.2.2 Latin America Microbiome Drugs Market Size by Type (2023-2028)
9.2.3 Latin America Microbiome Drugs Market Share by Type (2017-2028)
9.3 Latin America Microbiome Drugs Market Size by Symptom
9.3.1 Latin America Microbiome Drugs Market Size by Symptom (2017-2022)
9.3.2 Latin America Microbiome Drugs Market Size by Symptom (2023-2028)
9.3.3 Latin America Microbiome Drugs Market Share by Symptom (2017-2028)
9.4 Latin America Microbiome Drugs Market Size by Country
9.4.1 Latin America Microbiome Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Microbiome Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microbiome Drugs Market Size (2017-2028)
10.2 Middle East & Africa Microbiome Drugs Market Size by Type
10.2.1 Middle East & Africa Microbiome Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Microbiome Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Microbiome Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa Microbiome Drugs Market Size by Symptom
10.3.1 Middle East & Africa Microbiome Drugs Market Size by Symptom (2017-2022)
10.3.2 Middle East & Africa Microbiome Drugs Market Size by Symptom (2023-2028)
10.3.3 Middle East & Africa Microbiome Drugs Market Share by Symptom (2017-2028)
10.4 Middle East & Africa Microbiome Drugs Market Size by Country
10.4.1 Middle East & Africa Microbiome Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Microbiome Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Seres Therapeutics
11.1.1 Seres Therapeutics Company Details
11.1.2 Seres Therapeutics Business Overview
11.1.3 Seres Therapeutics Microbiome Drugs Introduction
11.1.4 Seres Therapeutics Revenue in Microbiome Drugs Business (2017-2022)
11.1.5 Seres Therapeutics Recent Developments
11.2 Assembly Biosciences
11.2.1 Assembly Biosciences Company Details
11.2.2 Assembly Biosciences Business Overview
11.2.3 Assembly Biosciences Microbiome Drugs Introduction
11.2.4 Assembly Biosciences Revenue in Microbiome Drugs Business (2017-2022)
11.2.5 Assembly Biosciences Recent Developments
11.3 Synthetic Biologics
11.3.1 Synthetic Biologics Company Details
11.3.2 Synthetic Biologics Business Overview
11.3.3 Synthetic Biologics Microbiome Drugs Introduction
11.3.4 Synthetic Biologics Revenue in Microbiome Drugs Business (2017-2022)
11.3.5 Synthetic Biologics Recent Developments
11.4 Interxon
11.4.1 Interxon Company Details
11.4.2 Interxon Business Overview
11.4.3 Interxon Microbiome Drugs Introduction
11.4.4 Interxon Revenue in Microbiome Drugs Business (2017-2022)
11.4.5 Interxon Recent Developments
11.5 PureTech
11.5.1 PureTech Company Details
11.5.2 PureTech Business Overview
11.5.3 PureTech Microbiome Drugs Introduction
11.5.4 PureTech Revenue in Microbiome Drugs Business (2017-2022)
11.5.5 PureTech Recent Developments
11.6 Synlogic
11.6.1 Synlogic Company Details
11.6.2 Synlogic Business Overview
11.6.3 Synlogic Microbiome Drugs Introduction
11.6.4 Synlogic Revenue in Microbiome Drugs Business (2017-2022)
11.6.5 Synlogic Recent Developments
11.7 Enterome BioScience
11.7.1 Enterome BioScience Company Details
11.7.2 Enterome BioScience Business Overview
11.7.3 Enterome BioScience Microbiome Drugs Introduction
11.7.4 Enterome BioScience Revenue in Microbiome Drugs Business (2017-2022)
11.7.5 Enterome BioScience Recent Developments
11.8 4D Pharma
11.8.1 4D Pharma Company Details
11.8.2 4D Pharma Business Overview
11.8.3 4D Pharma Microbiome Drugs Introduction
11.8.4 4D Pharma Revenue in Microbiome Drugs Business (2017-2022)
11.8.5 4D Pharma Recent Developments
11.9 Second Genome
11.9.1 Second Genome Company Details
11.9.2 Second Genome Business Overview
11.9.3 Second Genome Microbiome Drugs Introduction
11.9.4 Second Genome Revenue in Microbiome Drugs Business (2017-2022)
11.9.5 Second Genome Recent Developments
11.10 AOBiome
11.10.1 AOBiome Company Details
11.10.2 AOBiome Business Overview
11.10.3 AOBiome Microbiome Drugs Introduction
11.10.4 AOBiome Revenue in Microbiome Drugs Business (2017-2022)
11.10.5 AOBiome Recent Developments
11.11 Rebiotix
11.11.1 Rebiotix Company Details
11.11.2 Rebiotix Business Overview
11.11.3 Rebiotix Microbiome Drugs Introduction
11.11.4 Rebiotix Revenue in Microbiome Drugs Business (2017-2022)
11.11.5 Rebiotix Recent Developments
11.12 Metabiomics
11.12.1 Metabiomics Company Details
11.12.2 Metabiomics Business Overview
11.12.3 Metabiomics Microbiome Drugs Introduction
11.12.4 Metabiomics Revenue in Microbiome Drugs Business (2017-2022)
11.12.5 Metabiomics Recent Developments
11.13 Ritter Pharmaceuticals
11.13.1 Ritter Pharmaceuticals Company Details
11.13.2 Ritter Pharmaceuticals Business Overview
11.13.3 Ritter Pharmaceuticals Microbiome Drugs Introduction
11.13.4 Ritter Pharmaceuticals Revenue in Microbiome Drugs Business (2017-2022)
11.13.5 Ritter Pharmaceuticals Recent Developments
11.14 Symberix
11.14.1 Symberix Company Details
11.14.2 Symberix Business Overview
11.14.3 Symberix Microbiome Drugs Introduction
11.14.4 Symberix Revenue in Microbiome Drugs Business (2017-2022)
11.14.5 Symberix Recent Developments
11.15 OpenBiome
11.15.1 OpenBiome Company Details
11.15.2 OpenBiome Business Overview
11.15.3 OpenBiome Microbiome Drugs Introduction
11.15.4 OpenBiome Revenue in Microbiome Drugs Business (2017-2022)
11.15.5 OpenBiome Recent Developments
11.16 Azitra
11.16.1 Azitra Company Details
11.16.2 Azitra Business Overview
11.16.3 Azitra Microbiome Drugs Introduction
11.16.4 Azitra Revenue in Microbiome Drugs Business (2017-2022)
11.16.5 Azitra Recent Developments
11.17 Osel
11.17.1 Osel Company Details
11.17.2 Osel Business Overview
11.17.3 Osel Microbiome Drugs Introduction
11.17.4 Osel Revenue in Microbiome Drugs Business (2017-2022)
11.17.5 Osel Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Microbiome Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Oral Dosage Form
Table 3. Key Players of Enteric Capsules
Table 4. Global Microbiome Drugs Market Size Growth Rate by Symptom (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Microbiome Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Microbiome Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Microbiome Drugs Market Share by Region (2017-2022)
Table 8. Global Microbiome Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Microbiome Drugs Market Share by Region (2023-2028)
Table 10. Microbiome Drugs Market Trends
Table 11. Microbiome Drugs Market Drivers
Table 12. Microbiome Drugs Market Challenges
Table 13. Microbiome Drugs Market Restraints
Table 14. Global Microbiome Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Microbiome Drugs Revenue Share by Players (2017-2022)
Table 16. Global Top Microbiome Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Drugs as of 2021)
Table 17. Ranking of Global Top Microbiome Drugs Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Microbiome Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Microbiome Drugs Product Solution and Service
Table 21. Date of Enter into Microbiome Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Microbiome Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Microbiome Drugs Revenue Market Share by Type (2017-2022)
Table 25. Global Microbiome Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Microbiome Drugs Revenue Market Share by Type (2023-2028)
Table 27. Global Microbiome Drugs Market Size by Symptom (2017-2022) & (US$ Million)
Table 28. Global Microbiome Drugs Revenue Share by Symptom (2017-2022)
Table 29. Global Microbiome Drugs Forecasted Market Size by Symptom (2023-2028) & (US$ Million)
Table 30. Global Microbiome Drugs Revenue Share by Symptom (2023-2028)
Table 31. North America Microbiome Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Microbiome Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Microbiome Drugs Market Size by Symptom (2017-2022) & (US$ Million)
Table 34. North America Microbiome Drugs Market Size by Symptom (2023-2028) & (US$ Million)
Table 35. North America Microbiome Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Microbiome Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Microbiome Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Microbiome Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Microbiome Drugs Market Size by Symptom (2017-2022) & (US$ Million)
Table 40. Europe Microbiome Drugs Market Size by Symptom (2023-2028) & (US$ Million)
Table 41. Europe Microbiome Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Microbiome Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Microbiome Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Microbiome Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Microbiome Drugs Market Size by Symptom (2017-2022) & (US$ Million)
Table 46. Asia Pacific Microbiome Drugs Market Size by Symptom (2023-2028) & (US$ Million)
Table 47. Asia Pacific Microbiome Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Microbiome Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Microbiome Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Microbiome Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Microbiome Drugs Market Size by Symptom (2017-2022) & (US$ Million)
Table 52. Latin America Microbiome Drugs Market Size by Symptom (2023-2028) & (US$ Million)
Table 53. Latin America Microbiome Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Microbiome Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Microbiome Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Microbiome Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Microbiome Drugs Market Size by Symptom (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Microbiome Drugs Market Size by Symptom (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Microbiome Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Microbiome Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 61. Seres Therapeutics Company Details
Table 62. Seres Therapeutics Business Overview
Table 63. Seres Therapeutics Microbiome Drugs Product
Table 64. Seres Therapeutics Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
Table 65. Seres Therapeutics Recent Developments
Table 66. Assembly Biosciences Company Details
Table 67. Assembly Biosciences Business Overview
Table 68. Assembly Biosciences Microbiome Drugs Product
Table 69. Assembly Biosciences Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
Table 70. Assembly Biosciences Recent Developments
Table 71. Synthetic Biologics Company Details
Table 72. Synthetic Biologics Business Overview
Table 73. Synthetic Biologics Microbiome Drugs Product
Table 74. Synthetic Biologics Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
Table 75. Synthetic Biologics Recent Developments
Table 76. Interxon Company Details
Table 77. Interxon Business Overview
Table 78. Interxon Microbiome Drugs Product
Table 79. Interxon Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
Table 80. Interxon Recent Developments
Table 81. PureTech Company Details
Table 82. PureTech Business Overview
Table 83. PureTech Microbiome Drugs Product
Table 84. PureTech Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
Table 85. PureTech Recent Developments
Table 86. Synlogic Company Details
Table 87. Synlogic Business Overview
Table 88. Synlogic Microbiome Drugs Product
Table 89. Synlogic Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
Table 90. Synlogic Recent Developments
Table 91. Enterome BioScience Company Details
Table 92. Enterome BioScience Business Overview
Table 93. Enterome BioScience Microbiome Drugs Product
Table 94. Enterome BioScience Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
Table 95. Enterome BioScience Recent Developments
Table 96. 4D Pharma Company Details
Table 97. 4D Pharma Business Overview
Table 98. 4D Pharma Microbiome Drugs Product
Table 99. 4D Pharma Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
Table 100. 4D Pharma Recent Developments
Table 101. Second Genome Company Details
Table 102. Second Genome Business Overview
Table 103. Second Genome Microbiome Drugs Product
Table 104. Second Genome Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
Table 105. Second Genome Recent Developments
Table 106. AOBiome Company Details
Table 107. AOBiome Business Overview
Table 108. AOBiome Microbiome Drugs Product
Table 109. AOBiome Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
Table 110. AOBiome Recent Developments
Table 111. Rebiotix Company Details
Table 112. Rebiotix Business Overview
Table 113. Rebiotix Microbiome Drugs Product
Table 114. Rebiotix Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
Table 115. Rebiotix Recent Developments
Table 116. Metabiomics Company Details
Table 117. Metabiomics Business Overview
Table 118. Metabiomics Microbiome Drugs Product
Table 119. Metabiomics Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
Table 120. Metabiomics Recent Developments
Table 121. Ritter Pharmaceuticals Company Details
Table 122. Ritter Pharmaceuticals Business Overview
Table 123. Ritter Pharmaceuticals Microbiome Drugs Product
Table 124. Ritter Pharmaceuticals Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
Table 125. Ritter Pharmaceuticals Recent Developments
Table 126. Symberix Company Details
Table 127. Symberix Business Overview
Table 128. Symberix Microbiome Drugs Product
Table 129. Symberix Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
Table 130. Symberix Recent Developments
Table 131. OpenBiome Company Details
Table 132. OpenBiome Business Overview
Table 133. OpenBiome Microbiome Drugs Product
Table 134. OpenBiome Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
Table 135. OpenBiome Recent Developments
Table 136. Azitra Company Details
Table 137. Azitra Business Overview
Table 138. Azitra Microbiome Drugs Product
Table 139. Azitra Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
Table 140. Azitra Recent Developments
Table 141. Osel Company Details
Table 142. Osel Business Overview
Table 143. Osel Microbiome Drugs Product
Table 144. Osel Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
Table 145. Osel Recent Developments
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Microbiome Drugs Market Share by Type: 2021 VS 2028
Figure 2. Oral Dosage Form Features
Figure 3. Enteric Capsules Features
Figure 4. Global Microbiome Drugs Market Share by Symptom: 2021 VS 2028
Figure 5. Gastrointestinal Disorders Case Studies
Figure 6. Autoimmune Disorders Case Studies
Figure 7. Diabetes Case Studies
Figure 8. Cancer Case Studies
Figure 9. Others Case Studies
Figure 10. Microbiome Drugs Report Years Considered
Figure 11. Global Microbiome Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Microbiome Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Microbiome Drugs Market Share by Region: 2021 VS 2028
Figure 14. Global Microbiome Drugs Market Share by Players in 2021
Figure 15. Global Top Microbiome Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Drugs as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Microbiome Drugs Revenue in 2021
Figure 17. North America Microbiome Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Microbiome Drugs Market Size Market Share by Type (2017-2028)
Figure 19. North America Microbiome Drugs Market Size Market Share by Symptom (2017-2028)
Figure 20. North America Microbiome Drugs Market Size Share by Country (2017-2028)
Figure 21. United States Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Microbiome Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Microbiome Drugs Market Size Market Share by Type (2017-2028)
Figure 25. Europe Microbiome Drugs Market Size Market Share by Symptom (2017-2028)
Figure 26. Europe Microbiome Drugs Market Size Share by Country (2017-2028)
Figure 27. Germany Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Microbiome Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Microbiome Drugs Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Microbiome Drugs Market Size Market Share by Symptom (2017-2028)
Figure 36. Asia Pacific Microbiome Drugs Market Size Share by Region (2017-2028)
Figure 37. China Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Latin America Microbiome Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Microbiome Drugs Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Microbiome Drugs Market Size Market Share by Symptom (2017-2028)
Figure 46. Latin America Microbiome Drugs Market Size Share by Country (2017-2028)
Figure 47. Mexico Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Microbiome Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Microbiome Drugs Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Microbiome Drugs Market Size Market Share by Symptom (2017-2028)
Figure 52. Middle East and Africa Microbiome Drugs Market Size Share by Country (2017-2028)
Figure 53. Turkey Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Seres Therapeutics Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
Figure 57. Assembly Biosciences Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
Figure 58. Synthetic Biologics Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
Figure 59. Interxon Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
Figure 60. PureTech Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
Figure 61. Synlogic Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
Figure 62. Enterome BioScience Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
Figure 63. 4D Pharma Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
Figure 64. Second Genome Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
Figure 65. AOBiome Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
Figure 66. Rebiotix Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
Figure 67. Metabiomics Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
Figure 68. Ritter Pharmaceuticals Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
Figure 69. Symberix Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
Figure 70. OpenBiome Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
Figure 71. Azitra Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
Figure 72. Osel Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
  • Global Simple Syrup Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 93
    Simple Syrup market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Simple Syrup market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Liquid - Syrup - Other Segment by Application - Hospital - Family - Oth......
  • Global Anaesthetic Drugs and Pain Drugs Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 89
    Anaesthetic Drugs and Pain Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Anaesthetic Drugs and Pain Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Anaesthetic Drugs - Pain Drugs Segment by Application......
  • Global D- (+) -Mannose Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 95
    D-(+)-Mannose market is segmented by Type and by Application. Players, stakeholders, and other participants in the global D-(+)-Mannose market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Food Grade - Pharmaceutical Grade Segment by Application - Food Additives - Pharmac......
  • Global Small Molecule Active Pharmaceutical Ingredient Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 127
    Small Molecule Active Pharmaceutical Ingredient market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Small Molecule Active Pharmaceutical Ingredient market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Standard API - High Potency API ......
  • Global Wound-cleaning Potion Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 106
    Wound-cleaning Potion market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Wound-cleaning Potion market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Normal Saline - Hydrogen Peroxide - Metronidazole - Iodophor Disinfectant -......
  • Global Ocular Drug Delivery Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 110
    Ocular Drug Delivery market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Ocular Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Ocular Insert - Iontophoresis - Intraocular Implants - In Situ Gel & Punctal Plugs......
  • Global Transdermal Skin Patch Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 108
    Transdermal Skin Patch market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Transdermal Skin Patch market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Fentanyl Transdermal Skin Patch - Nicotine Transdermal Skin Patch - Clonidine Transderm......
  • Global Chronic Kidney Disease Drugs Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 113
    Chronic Kidney Disease Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Chronic Kidney Disease Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - ACE Inhibitors - Calcium Channel Blockers - Beta Blockers - Others......
  • Global Nanostructured Drug Market Insights and Forecast to 2028
    Published: 18-Jan-2022        Price: US 4900 Onwards        Pages: 128
    Nanostructured Drug market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Nanostructured Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - Liposomes - Polymeric Micelles - Solid lipid Nanoparticles - Microemulsion and Nanoemu......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs